Randomised clinical trial: symptoms of the irritable bowel syndrome are improved by a psycho-education group intervention.

Randomised clinical trial: symptoms of the irritable bowel syndrome are improved by a psycho-education group intervention.
复制标题

DOI:
10.1111/apt.12171
复制
发表时间:
2013-02
影响因子:
7.6
通讯作者:
Mayer EA
Mayer EA
中科院分区:
医学1区
文献类型:
--
作者:
Labus J;Gupta A;Gill HK;Posserud I;Mayer M;Raeen H;Bolus R;Simren M;Naliboff BD;Mayer EA

文献摘要

参考文献

被引文献

相似文献

Evidence supports the effectiveness of cognitive behavioral approaches in improving IBS symptoms. Duration, cost, and resistance of many patients towards a psychological therapy have limited their acceptance. We evaluated the effectiveness of a psycho-educational intervention on IBS symptoms. 69 IBS patients (72% female) were randomized to an intervention or a wait-list control group. The IBS class consisted of education on a biological mind body disease model emphasizing self-efficacy and practical relaxation techniques. Patients in the intervention showed significant improvement on GI symptom severity, visceral sensitivity, depression, and QoL post intervention and most of these gains were maintained at 3 month follow up (Hedge’s g =−.46 to .77). Moderated mediation analyses indicated change in anxiety, visceral sensitivity, QoL and catastrophizing due to the intervention had moderate mediation effects (Hedge’s g= −.38 to −.60) on improvements in GI symptom severity for patients entering the trial with low to average QoL. Also, change in GI symptom severity due to the intervention had moderate mediation effects on improvements in QoL especially patients with low to average levels of QoL at baseline. Moderated mediation analyses indicated mediation was less effective for patients entering the intervention with high QoL. A brief psycho-educational group intervention is efficacious in changing cognitions and fears about IBS symptoms, and these changes are associated with clinically meaningful improvement in IBS symptoms and QoL. The intervention seems particularly tailored to patients with low to moderate QoL baseline levels.
DOI: 10.5009/gnl.2011.5.3.253
发表时间: 2011-09
期刊: Gut and liver
影响因子: 3.4
作者:
Chey WD;Maneerattaporn M;Saad R
通讯作者: Saad R
DOI: 10.1056/nejmcp0801447
发表时间: 2008-04-17
影响因子: 158.5
作者:
Mayer, Emeran A.
通讯作者: Mayer, Emeran A.
DOI: 10.1111/j.1365-2036.2004.02007.x
发表时间: 2004-07-01
影响因子: 7.6
作者:
Labus, JS;Bolus, R;Naliboff, BD
通讯作者: Naliboff, BD
DOI: 10.1038/ajg.2011.139
发表时间: 2011-08-01
影响因子: 9.8
作者:
Ljotsson, Brjann;Hedman, Erik;Andersson, Gerhard
通讯作者: Andersson, Gerhard
DOI: 10.1007/s11136-011-9985-5
发表时间: 2012-06-01
影响因子: 3.5
作者:
Koloski, Natasha A.;Boyce, Philip M.;Talley, Nicholas J.
通讯作者: Talley, Nicholas J.